# OnCo record ramez-eskander (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/ramez-eskander/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "ramez-eskander" ;
  schema:name "Ramez N. Eskander"@en ;
  schema:description "Led NRG-GY018, which showed pembrolizumab with chemotherapy helps advanced endometrial cancer in both MMR-deficient and proficient disease."@en ;
  schema:url <https://onco.cc/people/ramez-eskander/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Eskander%20RN%5BAuthor%5D%20endometrial%20pembrolizumab> ;
  onco:tag "endometrial", "immunotherapy", "nrg-oncology" ;
  schema:jobTitle "Professor of Obstetrics, Gynecology and Reproductive Sciences, UC San Diego Moores Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0002-2101-1935> ;
  onco:cancers <https://onco.cc/cancers/endometrial/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:companies <https://onco.cc/companies/gog-foundation/> ;
  onco:institutions <https://onco.cc/institutions/ucsd-moores/> ;
  onco:trials <https://onco.cc/trials/nrg-gy018-keynote-868/> ;
  schema:affiliation <https://onco.cc/institutions/ucsd-moores/> .